Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): A 28-year perspective

Medicine

Volumn 81, Issue 2, 2002, Pages 87-100

  Arioglu, Elif ^a   Andewelt, Alexa ^a   Diabo, Crystal ^a   Bell, Melissa ^a   Taylor, Simeon I ^a   Gorden, Phillip ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL SURFACE RECEPTOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INSULIN; INSULIN RECEPTOR ANTIBODY; METFORMIN; STEROID; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; METABOLIC DISORDER; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT REDUCTION;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AUTOIMMUNE DISEASES; BODY COMPOSITION; CAUSE OF DEATH; CHILD; FEMALE; HUMANS; HYPERANDROGENISM; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLASMAPHERESIS; RECEPTOR, INSULIN; RETROSPECTIVE STUDIES; SYNDROME; UNITED STATES;

EID: 0036118261     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200203000-00001     Document Type: Article

References (82)

1. Antibodies and disorders of glucose metabolism: A courting couple
2. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I
3. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody
4. Insulin-resistant diabetes with insulin receptor autoantibodies in a male patient without acanghosis nigricans
5. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus
6. Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma
7. Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes
8. Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease
9. Vulnerability of cell-surface receptors to autoimmune reactions
10. Hypoglycaemia and Hodgkin's disease
11. Insulin-receptor interactions in liver cell membranes
12. Tissue-specific antibodies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia
13. Human autoantibodies directed against the human, but not the rat, insulin receptor
14. Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities
15. Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female
16. Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: Description of insulin receptor and postreceptor effects in vivo and in vitro
17. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: Description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action
18. Extreme insulin resistance due to anti-insulin receptor antibodies: A direct demonstration of autoantibody secretion by peripheral lymphocytes
19. Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats
20. Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome
21. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
22. Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B 4 infection
23. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report
24. Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: Spontaneous remission in a 15-year-old girl
25. The evolving clinical course of patients with insulin receptor autoantibodies: Spontaneous remission or receptor proliferation with hypoglycemia
26. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance
27. Insulin receptors in the liver: Specific binding of (125 I)insulin to the plasma membrane and its relation to insulin bioactivity
28. Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass
29. Gestational diabetes mellitus with profound insulin resistance. A case report
30. Autoimmune mechanisms of insulin resistance and hypoglycemia
31. Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L 1 fatty fibroblasts
32. Systemic lupus erythematosus presenting as hypoglycemia with insulin receptor antibodies
33. Combination of glomerulonephritis with diabetic glomerulopathy in a patient with diabetes mellitus due to autoantibody to insulin receptor
34. Insulin receptor autoantibody-induced pancreatic islet beta (B) cell hyperplasia
35. Direct demonstration that receptor crosslinking or aggregation is important in insulin action
36. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man
37. Effects of anti-insulin receptor autoantibodies on the metabolism of human adipocytes
38. Effects of antiinsulin receptor autoantibody on the metabolism of rat adipocytes
39. Antireceptor antibodies as probes of insulinlike growth factor receptor structure
40. Autoantibodies against the insulin receptor recognize the insulin binding subunits of an oligomeric receptor
41. Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies
42. Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies
43. Insulin-receptor antibody and hypoglycaemia associated with Hodgkin's disease
44. A case of insulin resistant diabetes mellitus due to insulin-receptor autoantibodies with Sjogren syndrome
45. Refractory hyperglycenua complicating an evolving connective tissue disease: Response to cyclosporine
46. Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor
47. Insulin receptor antibodies and insulin resistance
48. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antinsulin receptor antibodies
49. Treatment by plasma exchange of a patient with autoantibodies to the insulin receptor
50. The underlying insulin receptor in patients with antireceptor autoantibodies: Demonstration of normal binding and immunological properties
51. Islet amyloidosis in a patient with chronic massive insulin resistance due to antiinsulin receptor antibodies
52. Diabetes mellitus caused by insulin-receptor blockade and impaired sensitivity to insulin
53. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors
54. Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child
55. Characterization of purified autoantibodies to the insulin receptor from six patients with type B insulin resistance
56. Autoimmune thrombocytopenia and primary biliary cirrhosis with hypoglycemia and insulin receptor autoantibodies. A case report
57. Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein
58. Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin
59. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis
60. Monoclonal gammopathy with an insulin binding IgG(K) M-component, associated with severe hypoglycaemia
61. Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients
62. Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia
63. Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies
64. Lilly lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene
65. Unusual forms of insulin resistance
66. Syndromes associated with insulin resistance and acanthosis nigricans
67. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor
68. Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor
69. Hypoglycemia associated with antibodies to the insulin receptor
70. Anti-receptor antibodies mimic the effect of insulin to down-regulate insulin receptors in cultured human lymphoblastoid (IM-9) cells
71. Assay of antibodies directed against cell surface receptors
72. Remission of insulin resistant diabetes in two patients with antiinsulin receptor antibodies
73. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors
74. Insulin-receptor antibodies mimic a late insulin effect
75. Hypoglycemia due to antiinsulin receptor antibodies in systemic lupus erythematosus
76. Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease
77. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence for monoclonal insulin autoantibodies
78. Insulin resistance due to receptor antibodies: A complication of progressive systemic sclerosis
79. Receptor autoimmunity in endocrine disorders
80. Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: A case report
81. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies
82. The role of antireceptor antibodies in stimulating phosphorylation of the insulin receptor